Navigation Links
Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
Date:9/28/2007

include those who have been diagnosed with advanced or metastatic solid tumours that are refractory (have not responded) to standard therapy or for which no curative standard therapy exists.

The principal investigators for the trial are Dr. Kevin Harrington of the Targeted Therapy Laboratory, The Institute of Cancer Research, Cancer Research UK Centre for Cell and Molecular Biology and Honorary Consultant in Clinical Oncology at The Royal Marsden NHS Foundation Trust, London, UK, and Dr. Alan Melcher of the Cancer Research U.K. Clinical Centre at St. James's University Hospital in Leeds. The trial is enrolling patients at the Royal Marsden and St. James's Hospitals in the U.K.

Further results of the combination REOLYSIN(R) and radiation trial are scheduled to be presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in San Francisco October 22-26, 2007.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com

About The Institute of Cancer Research

The Institute of Cancer Research is Europe's leading cancer research centre with expert scientists working on cutting edge research. It was founded in 1909 to carry out research into the causes of cancer and to develop new strategies for its prevention, diagnosis, treatment and care. Website at: http://www.icr.ac.uk

The Institute works in a unique partnership with The Royal Marsden NHS Foundation Trust, forming the largest compr
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009).... 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph...chnology Co. Ltd.,( http://www.beikebiotech.com )... Care in New Delhi, India, November 22, 2009. Beik...rative medicine company. , The conference...A), aimed,to help podiatrists and researchers with...
(Date:12/2/2009)...swire/ -- Spectrum Blue Steel is emerging as one o...e planet. Through the efforts of True Green Energy...ling Specialist Leroy Johnston, who has been in th...t Spectrum Blue Steel is light years ahead of ever...ings because of the bi products recovered by using...
(Date:12/2/2009)...re/ -- Reportlinker.com announces that a new marke..., Carbondioxide Incubators - A Global Market P...64368/Carbondioxide-Incubators---A-Global-Market-P...itical equipment used in microbiology, genetics, c...ing a controlled environment to grow and store bio...
(Date:12/2/2009)...ewswire/ -- Nearly 600 medical research executives...vened to explore novel development approaches and ...rtnering for Cures meeting. ,, FasterCures, ...te, convened Partnering for Cures to facilitate ...tific discovery into an accessible therapy. This ...
Breaking Biology Technology:Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2
...s to develop drug candidate for prevention and ...nsplantation, LONDON, June 25 Silence Therapeuti...U.S. Food and Drug Administration (FDA) has,approv...tional New Drug,application (IND) for an siRNA the...tary chemistry. The product, DGFi, was discovered ...
... June 25 Lixte,Biotechnology Holdings (OTC Bullet...Institute of Neurological Disorders and Stroke (NI...e Biotechnology Holdings, Inc. extended,their Coop... to develop,drugs for the treatment of brain cance...d through September 2009., Dr. John S. Kovach, Pr...
... TraumaCure Inc. – makers of the groun...11; today announced that the company has received ...ion for its quality system for design, development...pany received FDA clearance to sell WoundStat in A...d. (Business Wire EON) June 24, 2008 -- With ISO ...
Other Biology Technology:FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics' Unique Proprietary Chemistry 2FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics' Unique Proprietary Chemistry 3Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs 2Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs 3 TraumaCure Receives Prestigious ISO 13485 Certification 2
(Date:12/3/2009)...the 1980s, Harald zur Hausen and his co-workers di...us (HPV) cause cervical cancer. Scientists soon fo...ate. It is known today that the main culprits are ... different cellular control functions, thus promot...his co-workers at DKFZ have now discovered another...
(Date:12/3/2009)...LADELPHIA Now in its 32nd year, the CTRC-AACR San...act the best in breast cancer science and world le...eradicating breast cancer. , This year, more th...ather at the Henry B. Gonzales Convention Center i...is a partnership between the American Association ...
(Date:12/3/2009)...est dwellers must be included in the design of the...oid a humanitarian crisis, according to a scientis...n Nature , Dr Simon Lewis argues that at least 50...penhagen, known as REDD (Reducing Emissions from D...orest dwellers directly, and their property rights...
Breaking Biology News(10 mins):Papillomavirus silences innate immune response 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Nanopoint Applies CE Mark to Its cellTRAY 28R 29 Imaging and Microfluidics Systems 12612 1Nanopoint Applies CE Mark to Its cellTRAY 28R 29 Imaging and Microfluidics Systems 12612 2Parents In Wisconsin Can Now Test Their Children For Lead Exposure Using Saliva 48843 1Parents In Wisconsin Can Now Test Their Children For Lead Exposure Using Saliva 48843 2Parents In Wisconsin Can Now Test Their Children For Lead Exposure Using Saliva 48843 3Parents In Wisconsin Can Now Test Their Children For Lead Exposure Using Saliva 48843 4After 10 Years A Stronger and More Enhanced Form of Viagra Now Available 48838 1After 10 Years A Stronger and More Enhanced Form of Viagra Now Available 48838 2After 10 Years A Stronger and More Enhanced Form of Viagra Now Available 48838 3After 10 Years A Stronger and More Enhanced Form of Viagra Now Available 48838 4
... monocytogenes invades the body, it commandeers it...ells. In a report published in the Journal of Biol...sight into the molecular mechanisms behind this in...Paper of the Week" in the March 25 issue of the Jo... for Biochemistry and Molecular Biology journal. ,...
...een a fly’s aerodynamic skill and human heart func...cated at the Advanced Photon Source at the U.S. De...a cardiac molecular motors expert from the Univers...ois Institute of Technology (IIT) and Caltech perf... , The research team, including David Maughan, Ph....
...nal wetlands, one of the world,s most bio-diverse ...pheral agricultural, industrial and urban developm... change, United Nations University experts warn. ,...area roughly equal to Florida ?in the heart of Sou...eshwater wetland, of active interest to U.S. scien...
Other Biology News:Scientists discover that host cell lipids facilitate bacterial movement 2X-Ray Beams And Fruit Fly 'Flight Simulator' Aid Scientists' View Of Muscle Power 2X-Ray Beams And Fruit Fly 'Flight Simulator' Aid Scientists' View Of Muscle Power 3South America's vast pantanal wetland may become next everglades, UNU experts warn 2South America's vast pantanal wetland may become next everglades, UNU experts warn 3South America's vast pantanal wetland may become next everglades, UNU experts warn 4South America's vast pantanal wetland may become next everglades, UNU experts warn 5South America's vast pantanal wetland may become next everglades, UNU experts warn 6
Cassette, Xba I from Takara Mirus Bio
Adaptor EcoR I Sma I from Takara Mirus Bio
Adaptor Sal I - Sma I from Takara Mirus Bio
DryStrip aligners from GE Healthcare, formerly Amersham Biosciences
Biology Products: